Even though in general cancer cases an increase in COX-2 levels is more common, it is very interesting that in the case of ovarian cancer a higher concentration of COX-1 is observed, which is why it has been suggested as a biomarker for early diagnosis. The gene discussed is PTGS1; the disease is cancer.